Andrew Quick Email and Phone Number
With over 20 years of experience in the medical device industry, I have dedicated my career to advancing healthcare through innovation and strategic leadership. My impact has been felt through developing and launching award-winning medical technologies, securing significant FDA approvals, and driving clinical and commercial success.In my various roles, I have cultivated strong relationships with key opinion leaders, stakeholders, and industry experts. These relationships have been crucial in driving product adoption and market expansion. My ability to manage cross-functional teams and collaborate effectively with diverse groups has been a cornerstone of my professional success.I thrive in innovative, diverse, and collaborative environments. I am driven by a curiosity to explore new solutions and a practical approach to problem-solving. My career has been characterized by a balance of high professional achievement and personal values, always maintaining a focus on quality and precision.WHY PEOPLE ENJOY WORKING WITH MEI consistently deliver high-quality results on time, bringing positivity and strategic thinking even in challenging situations. I'm known for being an open, collaborative, and adaptable team player who can easily switch between leading and supporting roles while maintaining focus and a constructive attitude.ZONE OF GENIUSAligning medical technology to medical unmet to yield medical products that will gain commercial traction by impacting patient care in an economically viable way.LEADERSHIP PHILOSOPHYIt’s essential to listen to the team to understand barriers to success and move forward, capitalizing on individual strengths without being overly constrained by corporate hierarchy.KORN FERRY CAREER GROWTH REPORT✦ Strong interpersonal skills, creating a vivid impression and excelling in public speaking.✦ Manages pressure and adaptable to feedback, combining curiosity with a practical approach to problem-solving and consistently pursuing task completion with a focus on high performance.✦ Balances professional achievement with personal values, showing a preference for innovative, diverse, and collaborative work environments while maintaining high standards of quality and precision.✦ Driven, reliable, and persistent, thriving in roles requiring accountability and the ability to influence positive outcomes, particularly in high-responsibility, fast-paced, and complex problem-solving situations.
Medtechstrat
View-
Founder And Principal AdvisorMedtechstrat Jan 2024 - PresentGuide industry-leading clients through complex clinical-regulatory landscapes to drive product adoption and market growth. Develop tailored messaging and engagement strategies for key stakeholders, including KOLs and investors.Provides strategic, technical, and clinical consulting to companies specializing in developing innovative medical technologies that leverage advanced scientific research to address complex clinical conditions, enhance patient recovery, and improve quality of life. Recent activities include preparing stakeholder and investment messaging, recommending clinical regulatory and clinical data publication strategies, and leading owners/leaders through long-term strategic planning exercises.
-
Advisory Board MemberNeurolight, Inc. Apr 2021 - Dec 2023Pomona, New York, Us -
Chief Tech OfficerAvita Medical Apr 2019 - Dec 2023Santa Clarita, California, UsI led a team of 30 in clinical research, medical affairs, and scientific affairs, effectively managing a substantial annual budget. Leveraging technological advances, I drove multiple product label expansions and developed comprehensive clinical education programs. In combination with a sophisticated publication strategy, these efforts significantly increased clinical use and strengthened our market position.I consistently briefed key analysts and investors on our technology and clinical strategy, which drove valuation and bolstered investor confidence. These strategic actions enhanced our reputation and market standing.I also managed two pipeline -sponsored- research programs, one a cell-based gene therapy program for epidermolysis bullosa in collaboration with the University of Colorado and a nanomedicine/mRNA concept for reverse-aging skin cells in collaboration with Houston Methodist.In addition to these accomplishments, I established our leadership among surgeons by developing best-in-class clinical education and training programs. I in-licensed a new product for our commercial portfolio. My efforts delivered industry-leading scientific and post-market clinical evidence, further solidifying our position in the MedTech sector. -
Svp Clinical DevelopmentAvita Medical May 2016 - Apr 2019Santa Clarita, California, UsI designed and executed clinical trials that were pivotal in securing original FDA approvals (Class III PMAs), bolstering confidence in our innovations and significantly driving AVITA's public valuation. Additionally, I launched Compassionate Use and Continued Access programs, enhancing pre-market product familiarity and acceptance.To further strengthen our financial and clinical standing, I co-developed and published a novel health economics model for the U.S. burn care pathway. This model improved product cost-effectiveness and had a positive impact on the budget. My efforts in managing a global clinical trial portfolio across Australia, the U.K., and the Netherlands leveraged broad OUS product approvals, advancing our clinical evidence base.Overall, my work was crucial in securing FDA approvals and successful commercial launches. These initiatives collectively enhanced our market position and demonstrated the effectiveness of our clinical strategies on a global scale.
-
Vp Research & TechnologyAvita Medical Jul 2010 - May 2016Santa Clarita, California, UsI led the research and development strategy, overseeing clinical trials to support product approvals and advancements, and collaborated with stakeholders to drive innovation and enhance the product pipeline. This role involved managing a substantial R&D budget and ensuring that our efforts were aligned with strategic goals.In securing non-dilutive funding, I obtained significant financial support from the Biomedical Advanced Research and Development Authority (BARDA, within HHS). This achievement was the result of thorough due diligence and authoring a comprehensive proposal. Additionally, I managed a considerable budget for a clinical trials in full- and partial-thickness burn injuries, collaborating closely with consultants and a contract research organization to ensure successful execution.These efforts were critical in advancing our product development and securing necessary approvals. By effectively managing resources and fostering key collaborations, I contributed to significant advancements in our research and development initiatives, ultimately driving innovation and enhancing our product offerings.
-
Sr Manager Clinical R&DAdvanced Bionics, Llc Oct 2005 - Jun 2010Santa Clarita, Ca, UsI oversaw pivotal and post-market clinical research, secured FDA approvals, developed intellectual property, and drove commercial adoption through key industry relationships and presentations. My role included managing a multimillion-dollar budget and leading a team of 10, ensuring successful execution and strategic alignment.In clinical trials, I executed pivotal studies for ClearVoice™ and HiResolution® Fidelity 120®, obtaining approvals of FDA PMA supplements and enhancing speech perception. For pipeline development, I secured FDA approval for in-house research on cochlear implant patients by writing an Investigational Device Exemption application.To drive commercial adoption, I developed key presentations for pivotal and post-market outcomes, cultivating relationships with industry key opinion leaders. Additionally, I presented research outcomes at major conferences, including a symposium at the Asia-Pacific Cochlear Implant conference in Sydney, Australia, in 2007. These efforts significantly advanced our clinical research and market presence. -
Co-Founder, R&D And Clinical AffairsSonamed Corporation Jan 1995 - Sep 2005I led the development and commercialization of award-winning newborn hearing screening devices, driving clinical success and market adoption, which ultimately resulted in a multimillion-dollar company acquisition. As a screening pioneer, I co-founded the company in 1995 and launched a newborn hearing screening device to address rising concerns about newborn deafness and its impact on learning, aligning the product with new legislation mandating hearing screening.Throughout the end-to-end development and scaling process, I wore multiple hats that propelled significant revenue growth and led to a lucrative buyout. These roles included inventing signal processing algorithms, developing software and user interfaces, managing clinical and commercial strategies, and fostering relationships with key opinion leaders.
Andrew Quick Education Details
-
Boston UniversityBiomedical Engineering -
Boston UniversityBiomedical Engineering
Frequently Asked Questions about Andrew Quick
What company does Andrew Quick work for?
Andrew Quick works for Medtechstrat
What is Andrew Quick's role at the current company?
Andrew Quick's current role is Executive Strategist, Therapeutic Medical Devices | Expert in Clinical Research & Clinical Regulatory | MedTech Innovator | Strategic Advisor | Commercial Success Driver.
What schools did Andrew Quick attend?
Andrew Quick attended Boston University, Boston University.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial